SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                    FORM 10-Q/A



    X             QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
- ----------        THE SECURITIES EXCHANGE ACT OF 1934

                  For the quarterly period ended  February 28, 1997

                  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)
- ----------        OF THE SECURITIES AND EXCHANGE ACT OF 1934

                  For the transition period from_________to_________

                           Commission File No. 0-19350

                                ViroGroup, Inc.

             (Exact name of registrant as specified in its charter)

          Florida                                               59-1671036
- -------------------------------                            --------------------
(State or other jurisdiction of                            (I.R.S. Employer
 incorporation or organization)                             Identification No.)



     428 Pine Island Road SW
       Cape Coral, Florida                                   33991
- ---------------------------------------                    ----------
(Address of principle executive office)                    (zip code)

Registrant's telephone number including area code:  (941) 574-1919
                                                    --------------

Indicated  by check  mark  whether  the  registrant  (1) has filed  all  reports
required to be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of
1934  during  the  preceding  12 months  (or for such  shorter  period  that the
registrant was required to file such reports),  and (2) has been subject to such
filing requirements for the past 90 days.

                                   Yes      X          No
                                       -----------        -----------

The number of shares  outstanding  of the  registrant's  common stock,  $.01 Par
Value, as of February 28, 1997 was 795,011.
















ITEM 6.    EXHIBITS AND REPORT ON FORM 8-K


10.0    Material Contracts

   
10.39   Loan Agreement, Line-of-Credit  Note and  Irrevocable  Letter of Credit,
        dated January 20, 1997. (1)
    

27      Financial Data Schedule (Electronic filing only)


Reports on Form 8-K

None

_________________________











































                                   SIGNATURES

Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.

                                 VIROGROUP, INC.




Date:  April 21, 1997                   By:    /s/ Charles S. Higgins, Jr.
                                             -----------------------------------
                                             Charles S. Higgins, Jr., President
                                             and Chief Executive Officer


Date:  April 21, 1997                   By:   /s/ DeWayne Baskette
                                             -----------------------------------
                                             DeWayne Baskette
                                             Chief Financial Officer